JP2024519999A - 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する安定な液体医薬組成物およびそれに関連する方法 - Google Patents
高い薬物充填量の中鎖脂肪酸トリグリセリドを有する安定な液体医薬組成物およびそれに関連する方法 Download PDFInfo
- Publication number
- JP2024519999A JP2024519999A JP2023572714A JP2023572714A JP2024519999A JP 2024519999 A JP2024519999 A JP 2024519999A JP 2023572714 A JP2023572714 A JP 2023572714A JP 2023572714 A JP2023572714 A JP 2023572714A JP 2024519999 A JP2024519999 A JP 2024519999A
- Authority
- JP
- Japan
- Prior art keywords
- liquid pharmaceutical
- pharmaceutical composition
- emulsion
- present disclosure
- forming excipients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192826P | 2021-05-25 | 2021-05-25 | |
| US63/192,826 | 2021-05-25 | ||
| PCT/US2022/030819 WO2022251288A1 (en) | 2021-05-25 | 2022-05-25 | Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519999A true JP2024519999A (ja) | 2024-05-21 |
| JP2024519999A5 JP2024519999A5 (cg-RX-API-DMAC7.html) | 2025-06-02 |
Family
ID=82115983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572714A Pending JP2024519999A (ja) | 2021-05-25 | 2022-05-25 | 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する安定な液体医薬組成物およびそれに関連する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240238199A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4346758A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024519999A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240012539A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117460495A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022283278A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3220907A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308512A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022251288A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202311798B (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024384650A1 (en) * | 2023-11-26 | 2026-07-09 | Cerecin Australia Pty Limited | Formulations of lipid nano emulsions with controlled pharmacokinetic profiles and methods of making and using the same |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08505367A (ja) * | 1992-10-16 | 1996-06-11 | スミスクライン・ビーチャム・コーポレイション | 医薬用エマルジョン組成物 |
| JP2020510102A (ja) * | 2017-03-15 | 2020-04-02 | セレシン・インコーポレーテッド | 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する医薬組成物およびそれに関連する方法 |
| WO2020180980A1 (en) * | 2019-03-04 | 2020-09-10 | Cerecin Inc. | Medium chain triglyceride formulations with improved bioavailiblity and methods related thereto |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2553132T3 (es) * | 2008-04-22 | 2015-12-04 | Azelis Deutschland Kosmetik Gmbh | Utilización de ésteres de ácido cítrico como emulsionantes W/O |
| BR112016018673B1 (pt) * | 2014-02-14 | 2023-10-17 | Jingjun Huang | Composição em nanoemulsão de óleo em água estável opticamente clara, método de produção da mesma, e, formulação de carreador |
| US11857931B2 (en) * | 2020-01-07 | 2024-01-02 | WAKAMONO joint stock company | Process for production of nano-microemulsion system of plant oil triglycerides |
-
2022
- 2022-05-25 AU AU2022283278A patent/AU2022283278A1/en active Pending
- 2022-05-25 EP EP22731926.6A patent/EP4346758A1/en active Pending
- 2022-05-25 JP JP2023572714A patent/JP2024519999A/ja active Pending
- 2022-05-25 CN CN202280037532.5A patent/CN117460495A/zh active Pending
- 2022-05-25 IL IL308512A patent/IL308512A/en unknown
- 2022-05-25 US US18/563,204 patent/US20240238199A1/en active Pending
- 2022-05-25 WO PCT/US2022/030819 patent/WO2022251288A1/en not_active Ceased
- 2022-05-25 CA CA3220907A patent/CA3220907A1/en active Pending
- 2022-05-25 KR KR1020237044473A patent/KR20240012539A/ko active Pending
-
2023
- 2023-12-21 ZA ZA2023/11798A patent/ZA202311798B/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08505367A (ja) * | 1992-10-16 | 1996-06-11 | スミスクライン・ビーチャム・コーポレイション | 医薬用エマルジョン組成物 |
| JP2020510102A (ja) * | 2017-03-15 | 2020-04-02 | セレシン・インコーポレーテッド | 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する医薬組成物およびそれに関連する方法 |
| WO2020180980A1 (en) * | 2019-03-04 | 2020-09-10 | Cerecin Inc. | Medium chain triglyceride formulations with improved bioavailiblity and methods related thereto |
Non-Patent Citations (2)
| Title |
|---|
| COLLOIDS AND SURFACES B: BIOINTERFACES, vol. 15, JPN6026020282, 1999, pages 117 - 125, ISSN: 0005865520 * |
| JOURNAL OF CONTROLLED RELEASE, vol. 105, JPN6026020281, 2005, pages 32 - 42, ISSN: 0005865519 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022283278A1 (en) | 2024-01-18 |
| ZA202311798B (en) | 2025-04-30 |
| WO2022251288A1 (en) | 2022-12-01 |
| EP4346758A1 (en) | 2024-04-10 |
| KR20240012539A (ko) | 2024-01-29 |
| US20240238199A1 (en) | 2024-07-18 |
| IL308512A (en) | 2024-01-01 |
| CN117460495A (zh) | 2024-01-26 |
| CA3220907A1 (en) | 2022-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7573541B2 (ja) | バイオアベイラビリティが改善した中鎖脂肪酸トリグリセリド製剤およびそれに関連する方法 | |
| US20230277459A1 (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| BRPI0407338B1 (pt) | nutriente dietético ou suplemento alimentar compreendendo uma composição comestível, bem como uma composição farmacêutica oralmente administrável e respectivos usos | |
| WO2022251288A1 (en) | Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| CN116322659A (zh) | 递送具有受控药物动力学、安全性和耐受性特性的中链甘油三酯的方法 | |
| HK40119699A (en) | Medium chain triglyceride formulations with improved bioavailability and methods related thereto | |
| HK40077205B (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| HK40077205A (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| HK40062099A (en) | Medium chain triglyceride formulations with improved bioavailability and methods related thereto | |
| HK40096010A (en) | Methods for delivering medium chain triglycerides with controlled pharmacokinetic, safety and tolerability profiles | |
| BR112019019098B1 (pt) | Composição farmacêutica em pó seca por pulverização tendo alto carregamento de fármaco de triglicerídeos de cadeia média e seu método de produção | |
| HK40014579B (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| HK40014579A (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250523 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250523 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20260325 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260521 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20260525 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260706 |